Palareti G, Biagi G, Legnani C, Bianchi D, Serra D, Savini R, Coccheri S
Dept. of Angiology and Blood Coagulation, University of Bologna, Italy.
Thromb Haemost. 1989 Dec 29;62(4):1053-6.
Twenty-one thyroprival patients, previously submitted to total thyroidectomy for tumours, were investigated during stabilized L-thyroxine supplementation and at the end of a 20-25 day "no-therapy" period, necessary for a 131I total body scintigraphy. During supplementation therapy a lower than normal mean beta-thromboglobulin (beta-TG) release level was found, the other blood clotting and platelet function tests being normal. After substitution therapy withdrawal, platelet function tests showed reduced adrenalin aggregation, increased collagen threshold aggregating concentrations, decreased beta-TG release values and reduced aggregation to ristocetin, whereas blood clotting tests showed prolonged aPTT values and reduced levels of factor VIII:C and vWf:Ag. We conclude that in acquired hypothyroidism the lowering of factor VIII:C and vWf:Ag (acquired von Willebrand disease) is associated with impaired platelet reactivity not only to ristocetin but also to collagen and especially adrenalin. In the patients investigated these changes were almost completely corrected by substitutive therapy with L-thyroxine at clinically effective doses.
21名因肿瘤接受过甲状腺全切除术的甲状腺功能减退患者,在稳定补充左旋甲状腺素期间以及为进行131I全身闪烁扫描而进行的20 - 25天“无治疗”期结束时接受了调查。在补充治疗期间,发现平均β - 血小板球蛋白(β - TG)释放水平低于正常,其他凝血和血小板功能测试均正常。停止替代治疗后,血小板功能测试显示肾上腺素聚集减少、胶原阈值聚集浓度增加、β - TG释放值降低以及对瑞斯托霉素的聚集减少,而凝血测试显示活化部分凝血活酶时间(aPTT)值延长以及因子VIII:C和血管性血友病因子抗原(vWf:Ag)水平降低。我们得出结论,在获得性甲状腺功能减退症中,因子VIII:C和vWf:Ag降低(获得性血管性血友病)与血小板反应性受损有关,不仅对瑞斯托霉素,而且对胶原尤其是肾上腺素的反应性也受损。在所研究的患者中,这些变化几乎可通过临床有效剂量的左旋甲状腺素替代治疗完全纠正。